Recent prospective studies indicate that schizophrenia manifests itself in behavioural abnormalities much earlier than was previously thought, supporting the view that schizophrenia is a developmental disorder.
Schizophrenia is a syndrome characterized by delusions, hallucinations, thought disorders and impaired social relationships. Patients come to the attention of doctors between the ages of 18 and 30. The outcome of the disease is variable, but as many as 60 % of patients will have difficulties coping with the disease for the rest of their life. The extent of these difficulties will vary and is almost impossible to predict at the onset of the disease. Many patients receive considerable help from treatment with neuroleptic drugs and the provision of appropriate social support in the community. The population lifetime risk of schizophrenia is about 1 % -at any one time, some 200000 patients have the disease in the UK, and almost 1 000000 in the USA [1] . The economic costs of the disease run to almost C2 billion a year in the UK. The variation in the severity of the disease is such that 97 % of the costs are incurred by less than 50 % of the patients.
Neuroleptic drugs revolutionized the treatment of schizophrenia in the 1960s, and newer 'atypical' neuroleptics such as clozapine and risperidone have produced additional significant gains in efficacy. But we are still in a position in which some 30 % of patients show only limited improvements when treated with neuroleptics, and 10-20 % show little or no improvement. Clearly, there is scope for a massive improvement in the efficacy of our therapeutic armoury. There is, however, a considerable snag. Improved efficacy is often contingent on a clearer understanding of the disease process. No advances were made on this front until recently. The result of this recent work has been a startling paradigm shift in our view of the disease process in schizophrenia. There is now a mounting body of evidence to support the view that schizophrenia is a consequence of a disorder in development of the brain.
For decades, schizophrenia was considered to be a 'functional' psychosis. A consequence of this was the tacit assumption that aberrant or degenerate brain structures played no significant role in the disease process. The dominance of 'psychogenic' hypotheses of the disease was only challenged after the introduction of imaging technologies. Following the seminal computer tomographic study of Johnstone and colleagues in 1976, numerous other workers demonstrated the presence of structural abnormalities in the brains of schizophrenia patients. Recent magnetic resonance imaging (MRI) studies have confirmed the presence of a diffuse reduction in brain volume (primarily of the grey matter), which is most pronounced in the regions of the medial temporal lobe [2, 3] . Positron emission tomography (PET) and MRI spectroscopy studies have also revealed changes in brain metabolism in the frontal and temporal lobes [4, 5] , and the changes in structure and metabolism appear to be related [5] . These studies are supported by a series of neuropathological investigations, which have also documented volume loss in the entorhinal cortex, hippocampus and related structures (see [6] for review).
Morphological investigations of the brains of schizophrenia patients have revealed disordered arrangements of neurons within the medial temporal lobe (entorhinal cortex, layer II pre-xt cells), coupled with varying degrees of volume or neuron loss in the same region [6] . A distorted distribution of NADPH-diaphorase positive interneurons has also been reported [7] . This latter find-'ing has been interpreted as indicating a perturbation in the functioning of the cortical subplate, with consequent disturbances in neuronal migration and cortical connectivity [7] . Thus, neurons going astray seem to be a central feature of the pathology of schizophrenia. The entorhinal cortex/parahippocampal gyrus forms a critical 'nodal way station' in the circuitry connecting the association cortex with the hippocampus and subcortical structures (Fig. 1) . The aberrant organization of neurons within the medial temporal lobe is therefore likely to have major consequences for higher cortical function.
Although there is general agreement that there are structural changes in schizophrenia brains, there has been considerable discussion -diplomatic-speak for acrimonious rows -about the mechanisms causing such changes. Candidate aetiological agents have been proposed, largely on the basis of epidemiological data, including viruses, obstetric complications, birth traumas and autoimmune disorders. From an epidemiological standpoint, the debate has been inconclusive. There is, however, considerable evidence from neuropathological studies to support the view that the abnormal brain development in schizophrenia results from a failure of normal brain development in the fetus. The structural changes observed do not appear to be associated with signs of degenerative or inflammatory processes [6] . These neuropathological studies provide the strongest evidence that the most likely cause of schizophrenia is a neurodevelopmental lesion, and that traumatic or degenerative aetiologies have, at best, a modest role in the pathogenesis of the disease [6] .
This view that schizophrenia is a neurodevelopmental disease leads to several simple, but profound, predictions. A, amygdala; AA, anterior amygdala; C, caudate; CG, central grey; CL, claustrum; DG, dentate gyrus; GP, globus pallidus; H, hippocampus; HY, hypothalamus; P, putamen; PG, parahippocampal gyrus; PP, perforant path; S, septum; SI, substantia inominata; T, thalamus; VT, ventral tegmentum; 6-46, Brodman areas.
One is that the structural changes should be present in the fetus, and must necessarily precede the onset of obvious clinical symptoms. Indeed, more subtle alterations in function or behaviour might be found in infancy, childhood and early adulthood, if they were looked for. In addition, the structural changes might be expected not to alter or progress during the course of the adult illness. Although these predictions can be simply stated, given the nature of the disease, testing them requires a huge effort. Recent studies have, nevertheless, attempted to address and test these predictions.
Two such recent studies [8, 9] have used prospectively gathered data, generated by projects (the National Survey of Health and Development, and the National Child Development Survey) aimed at investigating and examining the factors surrounding child birth and development, to track people who subsequently developed schizophrenia, and to compare their records of development with those of their peers who remained healthy. The studies appear to have led to similar findings. Patients destined to develop schizophrenia showed significant deficits compared to their peers on a range of behavioural measures.
Importantly, these deficits could be detected from the age of 4, when the children who later developed schizophrenia showed a greater tendency than other children to prefer solitary play. Although the deficits were more marked at early ages, in males at least the deficitsreduced educational achievement, more anxiety, poor speech development and poor motor control -were also seen at the ages of 7, 11 and 15. It should be emphasized that these changes are subtle, in that, although the children's teachers and parents noted differences, there were no obvious neurological impairments or gross developmental disorders requiring medical intervention. The confluence of data contained within these two careful studies is remarkable, and strongly supports the view that schizophrenia is a developmental disorder. In addition, the prediction that brain structural abnormalities associated with schizophrenia should not change during the course of the illness is borne out by recent studies in which the brains of schizophrenia patients have been imaged over periods of years [10] .
A remarkable change has thus taken place in our understanding of the biology of one of the greatest medical problems facing western society -schizophrenia. The painstaking documentation of the epidemiology, pathology and clinical course of the disease reveals a profile matching that expected of a disorder of brain development. Schizophrenia appears to be a familial disorder of brain development, in which the genetic regulation of temporal lobe development goes astray (Fig. 2) . This has consequences for the unfolding developmental programme of other brain regions and leads, like ripples in a pond, to diffuse effects on other anatomically linked but distant brain regions.
Recent advances in our understanding of normal brain development might provide us with a framework for understanding other puzzling features of the disease, such as why the temporal lobe is preferentially affected, why the left hemisphere tends to be more affected than the right, and how the deficits caused by aberrant development are change from subtle behavioural, social and cognitive symptoms, which are noticed but tolerated in childhood, to the full blown delusions, hallucinations .and thought disorder that overwhelm the adult. These advances are giving us a clearer view of the molecular mechanisms of brain development that probably underlie the pathogenesis of schizophrenia. Creative fusion between neuroscience, developmental biology, genetics, embryology, anatomy and psychiatry is essential if we are to undo the Gordian Knot of schizophrenia and dramatically improve therapy.
